Skip to main content Skip to search Skip to main navigation

About Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine

The Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine is a high quality natriuretic peptide for cardiovascular research. It is an endogenous peptide produced by the heart; involved in blood pressure regulation. Produces natriuresis, diuresis and vasorelaxation in vivo. The Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine, H-SLRRSSCFGGRMDRIGAQSGLGCNSFRY-OH (C07-C23 disulfide bond) from JPT is produced under strict quality management.

Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine - Specifications

  • Peptide sequence: H-SLRRSSCFGGRMDRIGAQSGLGCNSFRY-OH (C07-C23 disulfide bond)
  • Amount: 0.5 mg
  • Purity: >95% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in plastic vial
  • Application(s): Cardiovascular Research
  • Condition(s)/Topic(s): Electrolyte balance, cardiovascular disease
  • Standard Delivery Time: approx. 3 weeks

Are you interested in other natriuretic peptides?Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

Natriuretic Peptides from JPT

Natriuretic peptides are peptide hormones that regulate the cardiovascular system. Natriuretic peptides display strong diuretic, natriuretic, and vasodilatory effects. These peptide hormones are regulating blood pressure, fluid-electrolyte balance, and cardiovascular function and are involved in inflammation, and apoptosis. As they are activated during heart failure, a major clinical application of natriuretic peptides is diagnosing heart failure.
There are five types of natriuretic peptides:

  • Atrial natriuretic peptide (ANP)
  • Brain natriuretic peptide (BNP)
  • C-type natriuretic peptide (CNP)
  • Urodilatin (URO)
  • Dendroaspis natriuretic peptide (DNP)

Benefits of JPT’s Natriuretic Peptides

  • Each peptide quality controlled and guaranteed for identity and purity
  • CoA and HPLC-MS data available
  • High batch-to-batch consistency
  • Synthesis protocols designed to avoid toxic contaminants and side products
  • Provision of freeze dried aliquots for enhanced stability
  • Proven track record for applications in clinical studies

References for Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine

References
Read References with Peptides made by JPT
Atrial Natriuretic Peptide (ANP) (1-28), Rat, Mouse is described in
Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype
Horvath et al

Documentation for Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine

Properties of Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine

Amount: 0.5 mg
Application: Cardiovascular research
Category: Natriuretic Peptides
Condition / Topic: cardiovascular disease, electrolyte balance
Layout: Freeze-dried in plastic vial
Organism: Human, Porcine
Protein Name: Other
Purity: >95% (HPLC-MS)
Quantification: No

Further Information to Atrial Natriuretic Peptide (ANP) (1-28), Human, Porcine

Information Values
Sequence: H-SLRRSSCFGGRMDRIGAQSGLGCNSFRY-OH (C07-C23 disulfide bond)
Specifications: 28mer cyclized peptide (C07-C23)
Loading...

Check our list of products, click and go.

Get a quote